Recent Finacing
Recent Raise
CytoPherx develops a Selective Cytopheretic Device—hollow-fiber dialysis filters integrated into renal replacement circuits to isolate/deactivate white blood cells and modulate acute inflammation in ICU kidney-injury patients.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors